Sulindac and Haematemesis - a phase IV clinical study of FDA data

Summary:

Haematemesis is reported as a side effect among people who take Sulindac (sulindac), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zantac, and have Metastases to bone.

The phase IV clinical study analyzes which people have Haematemesis when taking Sulindac. It is created by eHealthMe based on reports of 3,687 people who have side effects when taking Sulindac from the FDA, and is updated regularly.

What is Sulindac?

Sulindac has active ingredients of sulindac. It is often used in rheumatoid arthritis. eHealthMe is studying from 3,824 Sulindac users. Check the latest studies of Sulindac.

What is Haematemesis?

Haematemesis (vomiting of blood) is found to be associated with 1,450 drugs and 2,238 conditions by eHealthMe. Check the latest studies of Haematemesis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

3,687 people reported to have side effects when taking Sulindac.
Among them, 13 people (0.35%) have Haematemesis.

Could Sulindac cause Haematemesis?

Among these 13 people:

How long have people been on Sulindac when they have Haematemesis? *

  • < 1 month: 33.33 %
  • 1 - 6 months: 33.33 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 33.33 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Haematemesis when taking Sulindac? *

  • female: 23.08 %
  • male: 76.92 %

What is the age of people who have Haematemesis when taking Sulindac? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 15.38 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 7.69 %
  • 50-59: 7.69 %
  • 60+: 69.23 %

What are other drugs people take besides Sulindac? *

  1. Aspirin: 2 people, 15.38%
  2. Celebrex: 2 people, 15.38%
  3. Cyclophosphamide: 2 people, 15.38%
  4. Dexamethasone: 2 people, 15.38%
  5. Etoposide: 2 people, 15.38%
  6. Zantac: 2 people, 15.38%
  7. Ifosfamide: 1 person, 7.69%
  8. Bactrim Ds: 1 person, 7.69%
  9. Carboplatin: 1 person, 7.69%
  10. Celecoxib: 1 person, 7.69%

What are other side effects people have besides Haematemesis? *

  1. Gastric Haemorrhage (bleeding stomach): 3 people, 23.08%
  2. Haemoglobin Decreased: 3 people, 23.08%
  3. Haemorrhage (bleeding): 3 people, 23.08%
  4. Nausea (feeling of having an urge to vomit): 3 people, 23.08%
  5. Nausea And Vomiting: 3 people, 23.08%
  6. Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 2 people, 15.38%
  7. Gastritis Haemorrhagic (inflammation of stomach with bleeding): 2 people, 15.38%
  8. Hypotension (abnormally low blood pressure): 2 people, 15.38%
  9. Drug Toxicity: 2 people, 15.38%
  10. Melaena (the passage of black, tarry stools): 2 people, 15.38%

What are the existing conditions these people have? *

  1. Neuroblastoma Recurrent (reoccurrence of a cancer that forms in your nerve tissue): 2 people, 15.38%
  2. Neuroblastoma (a cancer that forms in your nerve tissue): 2 people, 15.38%
  3. Metastases To Bone (cancer spreads to bone): 2 people, 15.38%
  4. Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 1 person, 7.69%
  5. Radiation Necrosis (death of cell due to radiation): 1 person, 7.69%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.69%
  7. Neovascularisation (development of tiny, abnormal, leaky blood vessels inside the eye): 1 person, 7.69%
  8. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 7.69%
  9. Gastric Ulcer (stomach ulcer): 1 person, 7.69%
  10. Carcinoma (cancer): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Sulindac and have Haematemesis?

- Check whether Haematemesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sulindac:

Haematemesis treatments and more:

How severe was Haematemesis and when was it recovered:

Expand to all the drugs that have ingredients of sulindac:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sulindac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematemesis:

Browse all the conditions that are associated with Haematemesis:


How the study uses the data?

The study uses data from the FDA. It is based on sulindac (the active ingredients of Sulindac) and Sulindac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: